• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人结直肠癌组织中的纤溶酶原激活剂和纤溶酶原激活剂抑制剂并非由肿瘤细胞表达。

Plasminogen activators and plasminogen activator inhibitors in human colorectal carcinoma tissues are not expressed by the tumour cells.

作者信息

Koretz K, Möller P, Schwartz-Albiez R

机构信息

Institut für Immunologie und Genetik, Deutsches Krebsforschungszentrum, Heidelberg, F.R.G.

出版信息

Eur J Cancer. 1993;29A(8):1184-9. doi: 10.1016/s0959-8049(05)80312-0.

DOI:10.1016/s0959-8049(05)80312-0
PMID:8518031
Abstract

Plasminogen activators (PA) have been implicated with the degradation of extracellular matrix during the invasive growth of metastasising tumour cells. The significance of PA expression in tumour cells for the in vivo growth of malignant tumours is still a matter of debate. We, therefore, performed immunohistological studies on human colon tumours using monoclonal antibodies against urokinase- (u-PA) and tissue-type plasminogen activator (t-PA) as well as against plasminogen activator inhibitors 1 and 2 (PAI-1, PAI-2). Normal colorectal mucosa of seven samples was negative for all four constituents of the PA system. Tumour epithelium of 64 colorectal carcinomas and 10 liver metastases was consistently negative for both, PA and their inhibitors. However, two of four human colon carcinoma cell lines weakly expressed u-PA, PAI-1 and PAI-2. Intestinal dendritic or fibroblast-like cells within the tumour tissue strongly expressed u-PA and, at a lower level, also t-PA, PAI-1 and PAI-2. Vascular endothelial cells were weakly positive for all components of the PA system in colon carcinoma. Our findings indicate that colon carcinoma cells in their natural environment do not express constituents of the PA system. PA activity, previously found in colon carcinoma tissue, is most likely derived from interstitial cells.

摘要

纤溶酶原激活剂(PA)与转移性肿瘤细胞侵袭性生长过程中细胞外基质的降解有关。肿瘤细胞中PA表达对恶性肿瘤体内生长的意义仍存在争议。因此,我们使用抗尿激酶型纤溶酶原激活剂(u-PA)、组织型纤溶酶原激活剂(t-PA)以及抗纤溶酶原激活剂抑制剂1和2(PAI-1、PAI-2)的单克隆抗体,对人类结肠肿瘤进行了免疫组织学研究。7个样本的正常结直肠黏膜对PA系统的所有四种成分均呈阴性。64例结直肠癌和10例肝转移瘤的肿瘤上皮对PA及其抑制剂均持续呈阴性。然而,4个人类结肠癌细胞系中有2个弱表达u-PA、PAI-1和PAI-2。肿瘤组织内的肠道树突状或成纤维细胞样细胞强烈表达u-PA,t-PA、PAI-1和PAI-2表达水平较低。结肠癌中血管内皮细胞对PA系统的所有成分呈弱阳性。我们的研究结果表明,处于自然环境中的结肠癌细胞不表达PA系统的成分。先前在结肠癌组织中发现的PA活性很可能源自间质细胞。

相似文献

1
Plasminogen activators and plasminogen activator inhibitors in human colorectal carcinoma tissues are not expressed by the tumour cells.人结直肠癌组织中的纤溶酶原激活剂和纤溶酶原激活剂抑制剂并非由肿瘤细胞表达。
Eur J Cancer. 1993;29A(8):1184-9. doi: 10.1016/s0959-8049(05)80312-0.
2
Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis.人结直肠肿瘤中纤溶酶原激活剂及其抑制剂的失衡。尿激酶在结直肠癌发生中的意义。
Gastroenterology. 1991 Dec;101(6):1522-8. doi: 10.1016/0016-5085(91)90387-z.
3
Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer.卵巢癌患者血液和肿瘤液中的纤溶酶原激活剂及纤溶酶原激活剂抑制剂
Eur J Cancer. 1994;30A(9):1302-9. doi: 10.1016/0959-8049(94)90178-3.
4
Components of the plasminogen activation system in uveal melanoma--a clinico-pathological study.葡萄膜黑色素瘤中纤溶酶原激活系统的组成部分——一项临床病理研究
J Pathol. 1995 Jan;175(1):59-67. doi: 10.1002/path.1711750110.
5
Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.纤溶酶原激活剂及其抑制剂对杜克B期和C期结直肠癌患者生存预后的影响
Br J Cancer. 1997;75(12):1793-801. doi: 10.1038/bjc.1997.306.
6
Localization of plasminogen activators and plasminogen-activator inhibitors in human gingival tissues demonstrated by immunohistochemistry and in situ hybridization.通过免疫组织化学和原位杂交技术对人牙龈组织中纤溶酶原激活剂和纤溶酶原激活剂抑制剂的定位研究
Arch Oral Biol. 1999 Dec;44(12):1027-34. doi: 10.1016/s0003-9969(99)00098-9.
7
Plasminogen activator system in oral squamous cell carcinoma.口腔鳞状细胞癌中的纤溶酶原激活物系统
Br J Oral Maxillofac Surg. 2007 Dec;45(8):623-7. doi: 10.1016/j.bjoms.2007.04.021. Epub 2007 Jun 21.
8
Factors involved in the plasminogen activation system in human breast tumours.人类乳腺肿瘤中纤溶酶原激活系统涉及的因素。
Thromb Haemost. 1994 Jun;71(6):684-91.
9
Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.在22种人类肿瘤细胞系中分析纤溶酶原激活剂和抑制剂的蛋白质及信使核糖核酸水平。
Cancer Res. 1990 Mar 1;50(5):1488-94.
10
Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas.纤溶酶原激活剂与人类结肠癌的发展:正常黏膜、腺瘤性息肉及腺癌中的活性水平
Cancer Res. 1987 Sep 1;47(17):4654-7.

引用本文的文献

1
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients.抗血管内皮生长因子(VEGF)疗法对癌症患者未成熟髓样细胞和树突状细胞的影响。
Cancer Immunol Immunother. 2008 Aug;57(8):1115-24. doi: 10.1007/s00262-007-0441-x. Epub 2008 Jan 10.
2
Urokinase and the intestinal mucosa: evidence for a role in epithelial cell turnover.尿激酶与肠黏膜:上皮细胞更新作用的证据
Gut. 1998 Nov;43(5):656-63. doi: 10.1136/gut.43.5.656.
3
Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas.
纤溶酶原激活的改变与结直肠腺瘤中上皮细胞发育异常分级相关。
Br J Cancer. 1998;77(2):297-304. doi: 10.1038/bjc.1998.46.
4
In situ stromal expression of the urokinase/plasmin system correlates with epithelial dysplasia in colorectal adenomas.尿激酶/纤溶酶系统的原位基质表达与大肠腺瘤中的上皮发育异常相关。
Am J Pathol. 1997 Jan;150(1):283-95.
5
Secretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro.正常结肠上皮细胞在体外分泌尿激酶和纤溶酶原激活物抑制剂-1 。
Gut. 1994 Jul;35(7):969-75. doi: 10.1136/gut.35.7.969.
6
Cathepsin B and other proteases in human colorectal carcinoma.人结直肠癌中的组织蛋白酶B及其他蛋白酶
Am J Pathol. 1994 Aug;145(2):253-62.
7
Comparative evaluation of integrin alpha- and beta-chain expression in colorectal carcinoma cell lines and in their tumours of origin.结直肠癌细胞系及其原发肿瘤中整合素α链和β链表达的比较评估。
Virchows Arch. 1994;425(3):229-36. doi: 10.1007/BF00196144.